Rare Disease DataMart:
Two (2) highly curated files to strategically analyze at the disease, epidemiology, asset, indication, pipeline and company levels.
Cost = $10,000 Pay via PayPal (you will receive an email with a download link following confirmation of payment)
Insights & Perspectives
Age-related Macular Degeneration (AMD): Patient Treatment Challenges
AMD - Challenges in treatment of patient[...]
Adobe Acrobat document [123.4 KB]
AMD - Challenges in treatment of patient[...]
Adobe Acrobat document [123.4 KB]
Alzheimer's Disease (AD): Stakeholder Needs
AD Stakeholder Needs.pdf
Adobe Acrobat document [541.5 KB]
AD Stakeholder Needs.pdf
Adobe Acrobat document [541.5 KB]
Building a Franchise Strategy
20170601 AD Above Brand Strategies vf.p[...]
Adobe Acrobat document [209.6 KB]
20170601 AD Above Brand Strategies vf.p[...]
Adobe Acrobat document [209.6 KB]
CAG Differentiation - Cost Benefit
20170518 CAG Differentiation - Cost Bene[...]
Adobe Acrobat document [104.9 KB]
20170518 CAG Differentiation - Cost Bene[...]
Adobe Acrobat document [104.9 KB]
Case Dissection: Baricitinib for Rheumatoid Arthritis (RA)
Baricitinib Case Dissection vFS.pdf
Adobe Acrobat document [284.0 KB]
Baricitinib Case Dissection vFS.pdf
Adobe Acrobat document [284.0 KB]
Huge rise in Phase III abstracts: Will these new therapeutics succeed?
20170528 PIII from ASCO vFS.pdf
Adobe Acrobat document [143.4 KB]
20170528 PIII from ASCO vFS.pdf
Adobe Acrobat document [143.4 KB]
Print